Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Post by mariaroseon Aug 05, 2020 11:59pm
312 Views
Post# 31370680

Patents by Inventor Saeid Babaei

Patents by Inventor Saeid Babaei
Patents by Inventor Saeid Babaei

Saeid Babaei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200040067
    Abstract: The present disclosure provides anti-Salmonella antibodies or antibody fragments such as camelid single domain antibodies (VHHs), along with associated nucleic acids, host cells and phages. Methods of reducing the presence of Salmonella in an animal or an animal environment, methods and formulations for treating Salmonella infection, and methods of detecting Salmonella are also described.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 6, 2020
    Inventors: Ali Riazi, Rashida Williams, Dea Shahinas, Saeid Babaei, Zhun Yan
  • Patent number: 10421806
    Abstract: The present disclosure provides anti-Salmonella antibodies or antibody fragments, such as camelid single domain antibodies (VHHs), along with associated nucleic acids, host cells and phages. Methods of reducing the presence of Salmonella in an animal or an animal environment, methods and formulations for treating Salmonella infection, and methods of detecting Salmonella are also described.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: September 24, 2019
    Assignee: ABCELEX TECHNOLOGIES INC.
    Inventors: Ali Riazi, Rashida Williams, Dea Shahinas, Saeid Babaei, Zhun Yan
  • Publication number: 20180030120
    Abstract: The present disclosure provides anti-Salmonella antibodies or antibody fragments, such as camelid single domain antibodies (VHHs), along with associated nucleic acids, host cells and phages. Methods of reducing the presence of Salmonella in an animal or an animal environment, methods and formulations for treating Salmonella infection, and methods of detecting Salmonella are also described.
    Type: Application
    Filed: February 3, 2016
    Publication date: February 1, 2018
    Inventors: Ali Riazi, Rashida Williams, Dea Shahinas, Saeid Babaei, Zhun Yan
  • Publication number: 20080194491
    Abstract: Early onset of pulmonary disorders such as pulmonary hypertension are treated or prevented by administration of an apoptosis inhibitor or a survival factor. Early onset of such disorders may be diagnosed by assessing apoptosis in lung tissue.
    Type: Application
    Filed: December 24, 2003
    Publication date: August 14, 2008
    Inventors: Duncan J. Stewart, Saeid Babaei, David Courtman

<< Previous
Bullboard Posts
Next >>